Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medihoney versus mupirocin for prevention of peritoneal dialysis catheter-related infection
ACTRN12611000297921Phase 4Suspended
- Sponsor
- Department of Renal Medicine
- Start
- Apr 2011
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of manuka honey and mupirocin in peritoneal dialysis catheter-related infection (PDCRI), exit-site infection (ESI) and peritonitis (2 arms), sponsored by Department of Renal Medicine. Primary endpoint: Time to first catheter-related infection event. Started Apr 2011; status: suspended.
02
Drugs
manuka honeymupirocin
03
Conditions
peritoneal dialysis catheter-related infection (PDCRI)exit-site infection (ESI)peritonitis
Beyond the preview
Go deeper on ACTRN12611000297921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000297921.